Roche’s shares tumbled nearly 5% on news that a key pillar in the five-pronged clinical plan for the breast cancer asset ...
FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression‑free survival and overall survival versus standard ...
Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...
Chalk up another victory for “Conan the Bacterium”—a rugged germ that fresh research suggests could conquer the solar system.
Merck’s Keytruda will soon lose exclusivity, just as weight-loss giants Eli Lilly and Novo Nordisk press in with their blockbuster GLP-1s.
FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens ...
Chalk up another victory for “Conan the Bacterium”—a rugged germ that fresh research suggests could conquer the solar system.
Rough Draft Atlanta on MSN
'This is not a test' gives less than the bare minimum
In "This Is Not a Test", Olivia Holt plays Sloane, a suicidal teenager who is forced to confront her demons when a zombie apocalypse breaks out, but the film fails to provide enough depth to the ...
Selpercatinib demonstrated a highly statistically significant and clinically meaningful improvement in reducing the risk of disease recurrence or death Results from the LIBRETTO-432 trial build on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results